Gene Therapy — UPSC Importance

UPSC Importance Analysis

Gene therapy is a topic of paramount importance for the UPSC examination, reflecting its status as a frontier technology with profound implications for science, society, ethics, and governance. From a Prelims perspective, questions frequently test factual knowledge regarding different types of gene therapy (somatic vs.

germline), delivery vectors (viral vs. non-viral and specific examples like AAV, lentivirus), key therapeutic applications (SMA, LCA, CAR-T), and landmark approvals (Zolgensma, Luxturna, Casgevy). The role of Indian regulatory bodies like ICMR and CDSCO, along with relevant policy documents such as the New Drugs and Clinical Trials Rules, 2019, and the National Biotechnology Development Strategy 2021–25, are also high-probability areas.

Aspirants must be able to distinguish between gene therapy and gene editing (e.g., CRISPR-Cas9) and understand the specific mechanisms and applications of each. For Mains, gene therapy transcends pure science, becoming a critical subject for General Studies Paper 3 (Science and Technology, Biotechnology) and Paper 4 (Ethics, Integrity, and Aptitude).

Questions often revolve around the ethical dilemmas (germline modification, equitable access, informed consent), regulatory challenges in a developing country like India, the socio-economic impact (cost, affordability, medical tourism), and the interface between cutting-edge science and public policy.

The Vyyuha Analysis section highlights how gene therapy can address India's specific healthcare burdens, making it a highly relevant topic for policy-oriented questions. The ability to articulate a balanced view, acknowledging both the immense promise and the significant challenges, is crucial for high scores.

Furthermore, current affairs related to new approvals, clinical trials, and policy updates globally and in India will consistently feature in the examination, demanding continuous tracking and integration into static knowledge.

Vyyuha Exam Radar — PYQ Pattern

An analysis of UPSC Prelims and Mains questions from 2018-2024 reveals a consistent interest in advanced biotechnologies, with gene therapy emerging as a high-frequency topic. Prelims questions have primarily focused on factual recall: identifying different types of gene therapy (somatic vs.

germline), mechanisms of action (e.g., how viral vectors work), specific examples of approved therapies and the diseases they treat (e.g., Zolgensma for SMA), and the distinction between gene therapy and gene editing (CRISPR-Cas9).

Questions often involve multiple-choice statements testing conceptual clarity and the ability to differentiate between similar terms or applications. For Mains, the pattern indicates a shift towards analytical and evaluative questions.

These typically fall under GS Paper 3 (Science & Technology) and GS Paper 4 (Ethics). Common themes include the ethical implications of genetic interventions (especially germline editing, 'designer babies'), the regulatory challenges in India (ICMR, CDSCO), the socio-economic impact of high-cost therapies (affordability, access, equity), and the potential of gene therapy to address India's specific health burdens.

There's also a trend towards questions that require a critical assessment of government policies like the National Biotechnology Development Strategy. The frequency of questions on biotechnology, including gene therapy, has steadily increased, indicating its growing importance.

Vyyuha's Exam Radar suggests that future questions will continue to integrate current affairs (new approvals, clinical trials) with static concepts, demanding a holistic and interdisciplinary understanding.